Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 24264230

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2014 Feb 6
First author
Zhou Z

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2014 Feb 6;123(6):800-1. doi: 10.1182/blood-2013-12-540914.
    note
    Source null
    related pmid
    24505063
    relationship
    Comment in

Authors and identifiers

  1. name
    Zhou Z
    type
    Author
  2. name
    Sehn LH
    type
    Author
  3. name
    Rademaker AW
    type
    Author
  4. name
    Gordon LI
    type
    Author
  5. name
    Lacasce AS
    type
    Author
  6. name
    Crosby-Thompson A
    type
    Author
  7. name
    Vanderplas A
    type
    Author
  8. name
    Zelenetz AD
    type
    Author
  9. name
    Abel GA
    type
    Author
  10. name
    Rodriguez MA
    type
    Author
  11. name
    Nademanee A
    type
    Author
  12. name
    Kaminski MS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Zhou Z
    type
    Author
  2. name
    Sehn LH
    type
    Author
  3. name
    Rademaker AW
    type
    Author
  4. name
    Gordon LI
    type
    Author
  5. name
    Lacasce AS
    type
    Author
  6. name
    Crosby-Thompson A
    type
    Author
  7. name
    Vanderplas A
    type
    Author
  8. name
    Zelenetz AD
    type
    Author
  9. name
    Abel GA
    type
    Author
  10. name
    Rodriguez MA
    type
    Author
  11. name
    Nademanee A
    type
    Author
  12. name
    Kaminski MS
    type
    Author
bibliography ids
  1. nci-bib-8dc746d688648da8f6ff1d1e
book metadata
content sha256
262ab6e795766b369800140489b475346f16ef1fe3edf4c92c3f859b2067efe9
document type
citation
dois
  1. 10.1182/blood-2013-09-524108
electronic publication date
display
2013 Nov 21
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24264230
immutable id
pubmed:24264230@262ab6e795766b369800140489b475346f16ef1fe3edf4c92c3f859b2067efe9
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
6
name
Blood
nlm unique id
7603509
pages
837-42
volume
123
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2014 Feb 6;123(6):800-1. doi: 10.1182/blood-2013-12-540914.
    note
    Source null
    related pmid
    24505063
    relationship
    Comment in
outcomes validated
false
pmid
24264230
provenance
batch id
af10498814d931b53231
provider
NCBI PubMed ESummary
record sha256
3b9d2747ef5fa1ea7943c4ac9432da72bbfefb596a92f2acc8c2b7e9ad35d592
response sha256
077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
retrieved at
2026-09-09T23:47:00.193465+00:00
publication date
display
2014 Feb 6
precision
day
year
2014
publication types
  1. Journal Article
  2. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24264230/
title
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Preserved source evidence · Independent clinical review pending · Not medical advice